Business ❯ Pharmaceutical Industry

Partnerships

Investment Licensing Agreements Research and Development Telehealth Collaboration Agreements Collaborations Sarepta Therapeutics Market Strategies Market Competition Retail Partnerships Retail Pharmacy Distribution Agreements Biotechnology BioArctic and Eisai Market Access Marketing Strategies Funding Innovation Product Development Strategic Collaborations Generic Manufacturing Biogen Product Launches Novo Nordisk Marketing Practices

AstraZeneca Strikes $1.2 Billion CSPC Pact for Once‑Monthly Obesity and Diabetes Programs

The lead asset SYH2082 is progressing into Phase 1 following the signing.

FDA Grants Priority Review to Leqembi Autoinjector for Weekly At-Home Starting Dose

Illumina Launches Billion Cell Atlas to Train AI in Drug Discovery

GSK and Ionis Report Phase 3 Success for Hepatitis B Drug, Plan Q1 Filings

AstraZeneca’s LATIFY Phase 3 Finds No Survival Benefit for Ceralasertib Plus Imfinzi in Pre-Treated NSCLC

Sanofi Secures Global Rights to ADEL’s Alzheimer’s Antibody in Deal Worth Up to $1.04 Billion

Regeneron, Tessera Strike $150 Million Gene-Editing Pact for Alpha‑1 Antitrypsin Deficiency

UK Approves Once-Every-Four-Weeks IV Maintenance Dosing for Leqembi in Early Alzheimer’s

Novo Nordisk Slashes Wegovy Price in India by Up to 37% to Take On Mounjaro

Lilly Licenses MeiraGTx Eye Gene Therapy in Deal Worth Up to $475 Million

Lilly Taps Walmart for First Retail Pickup of Discounted Zepbound Vials Starting Mid-November